Summary

According to this study, the global Pharmacovigilance (PV) Outsourcing market size will reach US$ million by 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Pharmacovigilance (PV) Outsourcing Industry Forecast” looks at past sales and reviews total world Pharmacovigilance (PV) Outsourcing sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmacovigilance (PV) Outsourcing sales for 2025 through 2031. With Pharmacovigilance (PV) Outsourcing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmacovigilance (PV) Outsourcing industry.
This Insight Report provides a comprehensive analysis of the global Pharmacovigilance (PV) Outsourcing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmacovigilance (PV) Outsourcing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmacovigilance (PV) Outsourcing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmacovigilance (PV) Outsourcing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmacovigilance (PV) Outsourcing.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacovigilance (PV) Outsourcing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Segmentation by Application:
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmacovigilance (PV) Outsourcing Market Size (2020-2031)
2.1.2 Pharmacovigilance (PV) Outsourcing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmacovigilance (PV) Outsourcing by Country/Region (2020, 2024 & 2031)
2.2 Pharmacovigilance (PV) Outsourcing Segment by Type
2.2.1 Contract Research Organizations (CROs)
2.2.2 Business Process Outsourcing (BPOs)
2.3 Pharmacovigilance (PV) Outsourcing Market Size by Type
2.3.1 Pharmacovigilance (PV) Outsourcing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmacovigilance (PV) Outsourcing Market Size Market Share by Type (2020-2025)
2.4 Pharmacovigilance (PV) Outsourcing Segment by Application
2.4.1 Premarketing Clinical Trial
2.4.2 Post-marketing Clinical Practice
2.4.3 Other
2.5 Pharmacovigilance (PV) Outsourcing Market Size by Application
2.5.1 Pharmacovigilance (PV) Outsourcing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmacovigilance (PV) Outsourcing Market Size Market Share by Application (2020-2025)
3 Pharmacovigilance (PV) Outsourcing Market Size by Player
3.1 Pharmacovigilance (PV) Outsourcing Market Size Market Share by Player
3.1.1 Global Pharmacovigilance (PV) Outsourcing Revenue by Player (2020-2025)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Player (2020-2025)
3.2 Global Pharmacovigilance (PV) Outsourcing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmacovigilance (PV) Outsourcing by Region
4.1 Pharmacovigilance (PV) Outsourcing Market Size by Region (2020-2025)
4.2 Global Pharmacovigilance (PV) Outsourcing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmacovigilance (PV) Outsourcing Market Size Growth (2020-2025)
4.4 APAC Pharmacovigilance (PV) Outsourcing Market Size Growth (2020-2025)
4.5 Europe Pharmacovigilance (PV) Outsourcing Market Size Growth (2020-2025)
4.6 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmacovigilance (PV) Outsourcing Market Size by Country (2020-2025)
5.2 Americas Pharmacovigilance (PV) Outsourcing Market Size by Type (2020-2025)
5.3 Americas Pharmacovigilance (PV) Outsourcing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacovigilance (PV) Outsourcing Market Size by Region (2020-2025)
6.2 APAC Pharmacovigilance (PV) Outsourcing Market Size by Type (2020-2025)
6.3 APAC Pharmacovigilance (PV) Outsourcing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2020-2025)
7.2 Europe Pharmacovigilance (PV) Outsourcing Market Size by Type (2020-2025)
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing by Region (2020-2025)
8.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Type (2020-2025)
8.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmacovigilance (PV) Outsourcing Market Forecast
10.1 Global Pharmacovigilance (PV) Outsourcing Forecast by Region (2026-2031)
10.1.1 Global Pharmacovigilance (PV) Outsourcing Forecast by Region (2026-2031)
10.1.2 Americas Pharmacovigilance (PV) Outsourcing Forecast
10.1.3 APAC Pharmacovigilance (PV) Outsourcing Forecast
10.1.4 Europe Pharmacovigilance (PV) Outsourcing Forecast
10.1.5 Middle East & Africa Pharmacovigilance (PV) Outsourcing Forecast
10.2 Americas Pharmacovigilance (PV) Outsourcing Forecast by Country (2026-2031)
10.2.1 United States Market Pharmacovigilance (PV) Outsourcing Forecast
10.2.2 Canada Market Pharmacovigilance (PV) Outsourcing Forecast
10.2.3 Mexico Market Pharmacovigilance (PV) Outsourcing Forecast
10.2.4 Brazil Market Pharmacovigilance (PV) Outsourcing Forecast
10.3 APAC Pharmacovigilance (PV) Outsourcing Forecast by Region (2026-2031)
10.3.1 China Pharmacovigilance (PV) Outsourcing Market Forecast
10.3.2 Japan Market Pharmacovigilance (PV) Outsourcing Forecast
10.3.3 Korea Market Pharmacovigilance (PV) Outsourcing Forecast
10.3.4 Southeast Asia Market Pharmacovigilance (PV) Outsourcing Forecast
10.3.5 India Market Pharmacovigilance (PV) Outsourcing Forecast
10.3.6 Australia Market Pharmacovigilance (PV) Outsourcing Forecast
10.4 Europe Pharmacovigilance (PV) Outsourcing Forecast by Country (2026-2031)
10.4.1 Germany Market Pharmacovigilance (PV) Outsourcing Forecast
10.4.2 France Market Pharmacovigilance (PV) Outsourcing Forecast
10.4.3 UK Market Pharmacovigilance (PV) Outsourcing Forecast
10.4.4 Italy Market Pharmacovigilance (PV) Outsourcing Forecast
10.4.5 Russia Market Pharmacovigilance (PV) Outsourcing Forecast
10.5 Middle East & Africa Pharmacovigilance (PV) Outsourcing Forecast by Region (2026-2031)
10.5.1 Egypt Market Pharmacovigilance (PV) Outsourcing Forecast
10.5.2 South Africa Market Pharmacovigilance (PV) Outsourcing Forecast
10.5.3 Israel Market Pharmacovigilance (PV) Outsourcing Forecast
10.5.4 Turkey Market Pharmacovigilance (PV) Outsourcing Forecast
10.6 Global Pharmacovigilance (PV) Outsourcing Forecast by Type (2026-2031)
10.7 Global Pharmacovigilance (PV) Outsourcing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Pharmacovigilance (PV) Outsourcing Forecast
11 Key Players Analysis
11.1 Accenture
11.1.1 Accenture Company Information
11.1.2 Accenture Pharmacovigilance (PV) Outsourcing Product Offered
11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Accenture Main Business Overview
11.1.5 Accenture Latest Developments
11.2 C3i Solutions
11.2.1 C3i Solutions Company Information
11.2.2 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Offered
11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 C3i Solutions Main Business Overview
11.2.5 C3i Solutions Latest Developments
11.3 Clintec
11.3.1 Clintec Company Information
11.3.2 Clintec Pharmacovigilance (PV) Outsourcing Product Offered
11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Clintec Main Business Overview
11.3.5 Clintec Latest Developments
11.4 Covance
11.4.1 Covance Company Information
11.4.2 Covance Pharmacovigilance (PV) Outsourcing Product Offered
11.4.3 Covance Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Covance Main Business Overview
11.4.5 Covance Latest Developments
11.5 Deloitte Touche Tohmatsu Limited
11.5.1 Deloitte Touche Tohmatsu Limited Company Information
11.5.2 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Offered
11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Deloitte Touche Tohmatsu Limited Main Business Overview
11.5.5 Deloitte Touche Tohmatsu Limited Latest Developments
11.6 ELC Group
11.6.1 ELC Group Company Information
11.6.2 ELC Group Pharmacovigilance (PV) Outsourcing Product Offered
11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 ELC Group Main Business Overview
11.6.5 ELC Group Latest Developments
11.7 Ergomed
11.7.1 Ergomed Company Information
11.7.2 Ergomed Pharmacovigilance (PV) Outsourcing Product Offered
11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Ergomed Main Business Overview
11.7.5 Ergomed Latest Developments
11.8 iGATE Corporation
11.8.1 iGATE Corporation Company Information
11.8.2 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Offered
11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 iGATE Corporation Main Business Overview
11.8.5 iGATE Corporation Latest Developments
11.9 iMED Global Corporation
11.9.1 iMED Global Corporation Company Information
11.9.2 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Offered
11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 iMED Global Corporation Main Business Overview
11.9.5 iMED Global Corporation Latest Developments
11.10 IQVIA
11.10.1 IQVIA Company Information
11.10.2 IQVIA Pharmacovigilance (PV) Outsourcing Product Offered
11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 IQVIA Main Business Overview
11.10.5 IQVIA Latest Developments
11.11 MarksMan Healthcare
11.11.1 MarksMan Healthcare Company Information
11.11.2 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Offered
11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 MarksMan Healthcare Main Business Overview
11.11.5 MarksMan Healthcare Latest Developments
11.12 Medpace Holdings
11.12.1 Medpace Holdings Company Information
11.12.2 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Offered
11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Medpace Holdings Main Business Overview
11.12.5 Medpace Holdings Latest Developments
11.13 Novartis
11.13.1 Novartis Company Information
11.13.2 Novartis Pharmacovigilance (PV) Outsourcing Product Offered
11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Novartis Main Business Overview
11.13.5 Novartis Latest Developments
11.14 Oracle Corporation
11.14.1 Oracle Corporation Company Information
11.14.2 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Offered
11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Oracle Corporation Main Business Overview
11.14.5 Oracle Corporation Latest Developments
11.15 Parexel
11.15.1 Parexel Company Information
11.15.2 Parexel Pharmacovigilance (PV) Outsourcing Product Offered
11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Parexel Main Business Overview
11.15.5 Parexel Latest Developments
11.16 PharmInvent
11.16.1 PharmInvent Company Information
11.16.2 PharmInvent Pharmacovigilance (PV) Outsourcing Product Offered
11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 PharmInvent Main Business Overview
11.16.5 PharmInvent Latest Developments
11.17 PrimeVigilance
11.17.1 PrimeVigilance Company Information
11.17.2 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Offered
11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 PrimeVigilance Main Business Overview
11.17.5 PrimeVigilance Latest Developments
11.18 Pure Drug Safety
11.18.1 Pure Drug Safety Company Information
11.18.2 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Offered
11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Pure Drug Safety Main Business Overview
11.18.5 Pure Drug Safety Latest Developments
11.19 Sciformix
11.19.1 Sciformix Company Information
11.19.2 Sciformix Pharmacovigilance (PV) Outsourcing Product Offered
11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Sciformix Main Business Overview
11.19.5 Sciformix Latest Developments
11.20 SIRO Clinpharm
11.20.1 SIRO Clinpharm Company Information
11.20.2 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Offered
11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 SIRO Clinpharm Main Business Overview
11.20.5 SIRO Clinpharm Latest Developments
11.21 Symogen
11.21.1 Symogen Company Information
11.21.2 Symogen Pharmacovigilance (PV) Outsourcing Product Offered
11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Symogen Main Business Overview
11.21.5 Symogen Latest Developments
12 Research Findings and Conclusion